Report Detail

Pharma & Healthcare Global Liver Failure Therapeutics Market Insights, Forecast to 2025

  • RnM2946245
  • |
  • 14 February, 2019
  • |
  • Global
  • |
  • 116 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

The global Liver Failure Therapeutics market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Liver Failure Therapeutics market based on company, product type, end user and key regions.

This report studies the global market size of Liver Failure Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Liver Failure Therapeutics in these regions.
This research report categorizes the global Liver Failure Therapeutics market by top players/brands, region, type and end user. This report also studies the global Liver Failure Therapeutics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Alfact Innovation
BioLineRx Ltd
Cell2B Advanced Therapeutics SA
Conatus Pharmaceuticals Inc
Immune Pharmaceuticals Inc
Mina Therapeutics Ltd
Mylan NV
Ocera Therapeutics Inc
PledPharma AB
Promethera Biosciences SA
Silence Therapeutics Plc
Unicyte AG
Ventria Bioscience
Vital Therapies Inc

Market size by Product
Ornithine Phenylacetate
MTL-CEBPA
F-573
BL-1220
PP-100
Others
Market size by End User
Clinic
Hospital
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Liver Failure Therapeutics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Liver Failure Therapeutics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Liver Failure Therapeutics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Liver Failure Therapeutics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Liver Failure Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Liver Failure Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Liver Failure Therapeutics Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Liver Failure Therapeutics Market Size Growth Rate by Product
      • 1.4.2 Ornithine Phenylacetate
      • 1.4.3 MTL-CEBPA
      • 1.4.4 F-573
      • 1.4.5 BL-1220
      • 1.4.6 PP-100
      • 1.4.7 Others
    • 1.5 Market by End User
      • 1.5.1 Global Liver Failure Therapeutics Market Size Growth Rate by End User
      • 1.5.2 Clinic
      • 1.5.3 Hospital
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Liver Failure Therapeutics Market Size
      • 2.1.1 Global Liver Failure Therapeutics Revenue 2014-2025
      • 2.1.2 Global Liver Failure Therapeutics Sales 2014-2025
    • 2.2 Liver Failure Therapeutics Growth Rate by Regions
      • 2.2.1 Global Liver Failure Therapeutics Sales by Regions
      • 2.2.2 Global Liver Failure Therapeutics Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Liver Failure Therapeutics Sales by Manufacturers
      • 3.1.1 Liver Failure Therapeutics Sales by Manufacturers
      • 3.1.2 Liver Failure Therapeutics Sales Market Share by Manufacturers
      • 3.1.3 Global Liver Failure Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Liver Failure Therapeutics Revenue by Manufacturers
      • 3.2.1 Liver Failure Therapeutics Revenue by Manufacturers (2014-2019)
      • 3.2.2 Liver Failure Therapeutics Revenue Share by Manufacturers (2014-2019)
    • 3.3 Liver Failure Therapeutics Price by Manufacturers
    • 3.4 Liver Failure Therapeutics Manufacturing Base Distribution, Product Types
      • 3.4.1 Liver Failure Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Liver Failure Therapeutics Product Type
      • 3.4.3 Date of International Manufacturers Enter into Liver Failure Therapeutics Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Liver Failure Therapeutics Sales by Product
    • 4.2 Global Liver Failure Therapeutics Revenue by Product
    • 4.3 Liver Failure Therapeutics Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Liver Failure Therapeutics Breakdown Data by End User

    6 North America

    • 6.1 North America Liver Failure Therapeutics by Countries
      • 6.1.1 North America Liver Failure Therapeutics Sales by Countries
      • 6.1.2 North America Liver Failure Therapeutics Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Liver Failure Therapeutics by Product
    • 6.3 North America Liver Failure Therapeutics by End User

    7 Europe

    • 7.1 Europe Liver Failure Therapeutics by Countries
      • 7.1.1 Europe Liver Failure Therapeutics Sales by Countries
      • 7.1.2 Europe Liver Failure Therapeutics Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Liver Failure Therapeutics by Product
    • 7.3 Europe Liver Failure Therapeutics by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Liver Failure Therapeutics by Countries
      • 8.1.1 Asia Pacific Liver Failure Therapeutics Sales by Countries
      • 8.1.2 Asia Pacific Liver Failure Therapeutics Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Liver Failure Therapeutics by Product
    • 8.3 Asia Pacific Liver Failure Therapeutics by End User

    9 Central & South America

    • 9.1 Central & South America Liver Failure Therapeutics by Countries
      • 9.1.1 Central & South America Liver Failure Therapeutics Sales by Countries
      • 9.1.2 Central & South America Liver Failure Therapeutics Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Liver Failure Therapeutics by Product
    • 9.3 Central & South America Liver Failure Therapeutics by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Liver Failure Therapeutics by Countries
      • 10.1.1 Middle East and Africa Liver Failure Therapeutics Sales by Countries
      • 10.1.2 Middle East and Africa Liver Failure Therapeutics Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Liver Failure Therapeutics by Product
    • 10.3 Middle East and Africa Liver Failure Therapeutics by End User

    11 Company Profiles

    • 11.1 Alfact Innovation
      • 11.1.1 Alfact Innovation Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Alfact Innovation Liver Failure Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Alfact Innovation Liver Failure Therapeutics Products Offered
      • 11.1.5 Alfact Innovation Recent Development
    • 11.2 BioLineRx Ltd
      • 11.2.1 BioLineRx Ltd Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 BioLineRx Ltd Liver Failure Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 BioLineRx Ltd Liver Failure Therapeutics Products Offered
      • 11.2.5 BioLineRx Ltd Recent Development
    • 11.3 Cell2B Advanced Therapeutics SA
      • 11.3.1 Cell2B Advanced Therapeutics SA Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Products Offered
      • 11.3.5 Cell2B Advanced Therapeutics SA Recent Development
    • 11.4 Conatus Pharmaceuticals Inc
      • 11.4.1 Conatus Pharmaceuticals Inc Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Conatus Pharmaceuticals Inc Liver Failure Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Conatus Pharmaceuticals Inc Liver Failure Therapeutics Products Offered
      • 11.4.5 Conatus Pharmaceuticals Inc Recent Development
    • 11.5 Immune Pharmaceuticals Inc
      • 11.5.1 Immune Pharmaceuticals Inc Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Immune Pharmaceuticals Inc Liver Failure Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Immune Pharmaceuticals Inc Liver Failure Therapeutics Products Offered
      • 11.5.5 Immune Pharmaceuticals Inc Recent Development
    • 11.6 Mina Therapeutics Ltd
      • 11.6.1 Mina Therapeutics Ltd Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Mina Therapeutics Ltd Liver Failure Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Mina Therapeutics Ltd Liver Failure Therapeutics Products Offered
      • 11.6.5 Mina Therapeutics Ltd Recent Development
    • 11.7 Mylan NV
      • 11.7.1 Mylan NV Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Mylan NV Liver Failure Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Mylan NV Liver Failure Therapeutics Products Offered
      • 11.7.5 Mylan NV Recent Development
    • 11.8 Ocera Therapeutics Inc
      • 11.8.1 Ocera Therapeutics Inc Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Ocera Therapeutics Inc Liver Failure Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Ocera Therapeutics Inc Liver Failure Therapeutics Products Offered
      • 11.8.5 Ocera Therapeutics Inc Recent Development
    • 11.9 PledPharma AB
      • 11.9.1 PledPharma AB Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 PledPharma AB Liver Failure Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 PledPharma AB Liver Failure Therapeutics Products Offered
      • 11.9.5 PledPharma AB Recent Development
    • 11.10 Promethera Biosciences SA
      • 11.10.1 Promethera Biosciences SA Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Promethera Biosciences SA Liver Failure Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Promethera Biosciences SA Liver Failure Therapeutics Products Offered
      • 11.10.5 Promethera Biosciences SA Recent Development
    • 11.11 Silence Therapeutics Plc
    • 11.12 Unicyte AG
    • 11.13 Ventria Bioscience
    • 11.14 Vital Therapies Inc

    12 Future Forecast

    • 12.1 Liver Failure Therapeutics Market Forecast by Regions
      • 12.1.1 Global Liver Failure Therapeutics Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Liver Failure Therapeutics Revenue Forecast by Regions 2019-2025
    • 12.2 Liver Failure Therapeutics Market Forecast by Product
      • 12.2.1 Global Liver Failure Therapeutics Sales Forecast by Product 2019-2025
      • 12.2.2 Global Liver Failure Therapeutics Revenue Forecast by Product 2019-2025
    • 12.3 Liver Failure Therapeutics Market Forecast by End User
    • 12.4 North America Liver Failure Therapeutics Forecast
    • 12.5 Europe Liver Failure Therapeutics Forecast
    • 12.6 Asia Pacific Liver Failure Therapeutics Forecast
    • 12.7 Central & South America Liver Failure Therapeutics Forecast
    • 12.8 Middle East and Africa Liver Failure Therapeutics Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Liver Failure Therapeutics Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Liver Failure Therapeutics . Industry analysis & Market Report on Liver Failure Therapeutics is a syndicated market report, published as Global Liver Failure Therapeutics Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Liver Failure Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,030.30
      4,545.45
      6,060.60
      3,658.20
      5,487.30
      7,316.40
      599,040.00
      898,560.00
      1,198,080.00
      329,277.00
      493,915.50
      658,554.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report